Discover 626 paid clinical trials in Nebraska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Nebraska provides a variety of paid research opportunities for both healthy volunteers and individuals with specific medical concerns. Research institutions in Omaha, Lincoln, and Bellevue are recruiting participants, offering access to advanced treatments and dedicated medical care.
Filter
1
Filter results
Results: 626
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
for
Breast Cancer
Location: New York NY, Fort Wayne IN, Omaha NE, Houston TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07205822
Phase3, Recruiting
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
for
Radiographic Axial Spondyloarthritis
Location: Quebec, Trois-Rivieres, Philadelphia PA, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07133633
Phase2, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Boston MA, New Haven CT, Manhasset NY, Rosedale NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Get alerts for new trials in your area by subscribing now
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Location: Chicoutimi, New York NY, Summit NJ, New Brunswick NJ,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06989437
Phase2, Phase3, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Boston MA, The Bronx NY, New York NY, East Brunswick NJ,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase3, Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Boston MA, New York NY, Hackensack NJ, Baltimore MD,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase2, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Boston MA, New Haven CT, Sherbrooke, New York NY,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase3, Recruiting
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
for
Severe Alopecia Areata
Location: Miami FL, Indianapolis IN, Papillion NE, Omaha NE,
Sponsor: Pfizer
Sex: All
Age: 6 - 14
Code: NCT07029828
Phase3, Recruiting
Study of COYA 302 for the Treatment of ALS
for
Amyotrophic Lateral Sclerosis (ALS)
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Coya Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07161999
Phase2, Phase3, Recruiting
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
for
Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: Montreal, Omaha NE
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07660055
Phase1, Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
for
Metastatic Gastric Adenocarcinoma,
Location: Westbrook ME, Florham Park NJ, Flemington NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07043400
Phase3, Recruiting
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
for
Pneumococcal Disease
Location: Fall River MA, East Syracuse NY, Richmond VA,
Sponsor: Pfizer
Sex: All
Age: 1 - 17
Code: NCT07660198
Phase3, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Hawthorne NY, The Bronx NY, Ocean City NJ, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor